Atlas Trials

DRV/r + RPV QD: Efficacy and Toxicity Reduction

Clinical trial NCT01792570 · COMPLETED

Trial details

NCT number
NCT01792570
Sponsor
ASST Fatebenefratelli Sacco
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Human Immunodeficiency Virus
Start date
2014-09-30
Primary completion
2018-12-31
Enrollment
37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.